Re: Evaluating the Safety and Potential Activity of URO-902 (hMaxi-K) Gene Transfer by Intravesical Instillation or Direct Injection into the Bladder Wall in Female Participants with Idiopathic (Non-Neurogenic) Overactive Bladder Syndrome and Detrusor Overactivity from Two Double-Blind, Imbalanced, Placebo-Controlled Randomized Phase 1 Trials

E. Rovner; T. C. Chai; S. Jacobs; G. Christ; K. E. Andersson; M. Efros; V. Nitti; K. Davies; A. R. McCullough; A. Melman; Alan J. Wein

doi:10.1097/JU.0000000000001223.02

Re: Evaluating the Safety and Potential Activity of URO-902 (hMaxi-K) Gene Transfer by Intravesical Instillation or Direct Injection into the Bladder Wall in Female Participants with Idiopathic (Non-Neurogenic) Overactive Bladder Syndrome and Detrusor Overactivity from Two Double-Blind, Imbalanced, Placebo-Controlled Randomized Phase 1 Trials

E. Rovner, T. C. Chai, S. Jacobs, G. Christ, K. E. Andersson, M. Efros, V. Nitti, K. Davies, A. R. McCullough, A. Melman, Alan J. Wein

Research output: Contribution to journal › Comment/debate

1 Scopus citations

Original language	English
Pages (from-to)	884-885
Number of pages	2
Journal	Journal of Urology
Volume	204
Issue number	4
DOIs	https://doi.org/10.1097/JU.0000000000001223.02
State	Published - 1 Oct 2020
Externally published	Yes

Access to Document

10.1097/JU.0000000000001223.02

Cite this

Rovner, E., Chai, T. C., Jacobs, S., Christ, G., Andersson, K. E., Efros, M., Nitti, V., Davies, K., McCullough, A. R., Melman, A., & Wein, A. J. (2020). Re: Evaluating the Safety and Potential Activity of URO-902 (hMaxi-K) Gene Transfer by Intravesical Instillation or Direct Injection into the Bladder Wall in Female Participants with Idiopathic (Non-Neurogenic) Overactive Bladder Syndrome and Detrusor Overactivity from Two Double-Blind, Imbalanced, Placebo-Controlled Randomized Phase 1 Trials. Journal of Urology, 204(4), 884-885. https://doi.org/10.1097/JU.0000000000001223.02

Rovner, E. ; Chai, T. C. ; Jacobs, S. et al. / Re : Evaluating the Safety and Potential Activity of URO-902 (hMaxi-K) Gene Transfer by Intravesical Instillation or Direct Injection into the Bladder Wall in Female Participants with Idiopathic (Non-Neurogenic) Overactive Bladder Syndrome and Detrusor Overactivity from Two Double-Blind, Imbalanced, Placebo-Controlled Randomized Phase 1 Trials. In: Journal of Urology. 2020 ; Vol. 204, No. 4. pp. 884-885.

@article{b36a1ef5c5d14880b4ee107c727c9bfa,

title = "Re: Evaluating the Safety and Potential Activity of URO-902 (hMaxi-K) Gene Transfer by Intravesical Instillation or Direct Injection into the Bladder Wall in Female Participants with Idiopathic (Non-Neurogenic) Overactive Bladder Syndrome and Detrusor Overactivity from Two Double-Blind, Imbalanced, Placebo-Controlled Randomized Phase 1 Trials",

author = "E. Rovner and Chai, {T. C.} and S. Jacobs and G. Christ and Andersson, {K. E.} and M. Efros and V. Nitti and K. Davies and McCullough, {A. R.} and A. Melman and Wein, {Alan J.}",

year = "2020",

month = oct,

day = "1",

doi = "10.1097/JU.0000000000001223.02",

language = "English",

volume = "204",

pages = "884--885",

journal = "Journal of Urology",

issn = "0022-5347",

publisher = "Wolters Kluwer Health",

number = "4",

}

Rovner, E, Chai, TC, Jacobs, S, Christ, G, Andersson, KE, Efros, M, Nitti, V, Davies, K, McCullough, AR, Melman, A & Wein, AJ 2020, 'Re: Evaluating the Safety and Potential Activity of URO-902 (hMaxi-K) Gene Transfer by Intravesical Instillation or Direct Injection into the Bladder Wall in Female Participants with Idiopathic (Non-Neurogenic) Overactive Bladder Syndrome and Detrusor Overactivity from Two Double-Blind, Imbalanced, Placebo-Controlled Randomized Phase 1 Trials', Journal of Urology, vol. 204, no. 4, pp. 884-885. https://doi.org/10.1097/JU.0000000000001223.02

Re: Evaluating the Safety and Potential Activity of URO-902 (hMaxi-K) Gene Transfer by Intravesical Instillation or Direct Injection into the Bladder Wall in Female Participants with Idiopathic (Non-Neurogenic) Overactive Bladder Syndrome and Detrusor Overactivity from Two Double-Blind, Imbalanced, Placebo-Controlled Randomized Phase 1 Trials. / Rovner, E.; Chai, T. C.; Jacobs, S. et al.
In: Journal of Urology, Vol. 204, No. 4, 01.10.2020, p. 884-885.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Re

T2 - Evaluating the Safety and Potential Activity of URO-902 (hMaxi-K) Gene Transfer by Intravesical Instillation or Direct Injection into the Bladder Wall in Female Participants with Idiopathic (Non-Neurogenic) Overactive Bladder Syndrome and Detrusor Overactivity from Two Double-Blind, Imbalanced, Placebo-Controlled Randomized Phase 1 Trials

AU - Rovner, E.

AU - Chai, T. C.

AU - Jacobs, S.

AU - Christ, G.

AU - Andersson, K. E.

AU - Efros, M.

AU - Nitti, V.

AU - Davies, K.

AU - McCullough, A. R.

AU - Melman, A.

AU - Wein, Alan J.

PY - 2020/10/1

Y1 - 2020/10/1

UR - http://www.scopus.com/inward/record.url?scp=85091126113&partnerID=8YFLogxK

U2 - 10.1097/JU.0000000000001223.02

DO - 10.1097/JU.0000000000001223.02

M3 - Comment/debate

C2 - 32715915

AN - SCOPUS:85091126113

SN - 0022-5347

VL - 204

SP - 884

EP - 885

JO - Journal of Urology

JF - Journal of Urology

IS - 4

ER -

Rovner E, Chai TC, Jacobs S, Christ G, Andersson KE, Efros M et al. Re: Evaluating the Safety and Potential Activity of URO-902 (hMaxi-K) Gene Transfer by Intravesical Instillation or Direct Injection into the Bladder Wall in Female Participants with Idiopathic (Non-Neurogenic) Overactive Bladder Syndrome and Detrusor Overactivity from Two Double-Blind, Imbalanced, Placebo-Controlled Randomized Phase 1 Trials. Journal of Urology. 2020 Oct 1;204(4):884-885. doi: 10.1097/JU.0000000000001223.02